BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25131200)

  • 1. A polymorphic enhancer near GREM1 influences bowel cancer risk through differential CDX2 and TCF7L2 binding.
    Lewis A; Freeman-Mills L; de la Calle-Mustienes E; Giráldez-Pérez RM; Davis H; Jaeger E; Becker M; Hubner NC; Nguyen LN; Zeron-Medina J; Bond G; Stunnenberg HG; Carvajal JJ; Gomez-Skarmeta JL; Leedham S; Tomlinson I
    Cell Rep; 2014 Aug; 8(4):983-90. PubMed ID: 25131200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of
    Mitroi AF; Leopa N; Dumitru E; Brînzan C; Tocia C; Dumitru A; Popescu RC
    Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 35893034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCF7L2, CASC8, and GREM1 polymorphism and colorectal cancer in south-eastern Romanian population.
    Mitroi AF; Leopa N; Dumitru E; Dumitru A; Tocia C; Popescu I; Mitroi A; Popescu RC
    Medicine (Baltimore); 2023 Feb; 102(7):e33056. PubMed ID: 36800588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The VTI1A-TCF4 colon cancer fusion protein is a dominant negative regulator of Wnt signaling and is transcriptionally regulated by intestinal homeodomain factor CDX2.
    Davidsen J; Larsen S; Coskun M; Gögenur I; Dahlgaard K; Bennett EP; Troelsen JT
    PLoS One; 2018; 13(7):e0200215. PubMed ID: 29975781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SNPs associated with colorectal cancer at 15q13.3 affect risk enhancers that modulate GREM1 gene expression.
    Fortini BK; Tring S; Devall MA; Ali MW; Plummer SJ; Casey G
    Hum Mutat; 2021 Mar; 42(3):237-245. PubMed ID: 33476087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1.
    Jaeger E; Leedham S; Lewis A; Segditsas S; Becker M; Cuadrado PR; Davis H; Kaur K; Heinimann K; Howarth K; ; East J; Taylor J; Thomas H; Tomlinson I
    Nat Genet; 2012 May; 44(6):699-703. PubMed ID: 22561515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCF4 and CDX2, major transcription factors for intestinal function, converge on the same cis-regulatory regions.
    Verzi MP; Hatzis P; Sulahian R; Philips J; Schuijers J; Shin H; Freed E; Lynch JP; Dang DT; Brown M; Clevers H; Liu XS; Shivdasani RA
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15157-62. PubMed ID: 20696899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer.
    Tomlinson IP; Carvajal-Carmona LG; Dobbins SE; Tenesa A; Jones AM; Howarth K; Palles C; Broderick P; Jaeger EE; Farrington S; Lewis A; Prendergast JG; Pittman AM; Theodoratou E; Olver B; Walker M; Penegar S; Barclay E; Whiffin N; Martin L; Ballereau S; Lloyd A; Gorman M; Lubbe S; ; ; ; Howie B; Marchini J; Ruiz-Ponte C; Fernandez-Rozadilla C; Castells A; Carracedo A; Castellvi-Bel S; Duggan D; Conti D; Cazier JB; Campbell H; Sieber O; Lipton L; Gibbs P; Martin NG; Montgomery GW; Young J; Baird PN; Gallinger S; Newcomb P; Hopper J; Jenkins MA; Aaltonen LA; Kerr DJ; Cheadle J; Pharoah P; Casey G; Houlston RS; Dunlop MG
    PLoS Genet; 2011 Jun; 7(6):e1002105. PubMed ID: 21655089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of CDX2 in the cross talk between TNF-α and Wnt signaling pathway in the colon cancer cell line Caco-2.
    Coskun M; Olsen AK; Bzorek M; Holck S; Engel UH; Nielsen OH; Troelsen JT
    Carcinogenesis; 2014 May; 35(5):1185-92. PubMed ID: 24501326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of the desmocollin 2 gene expression in human colon cancer cells is relieved by the homeodomain transcription factors Cdx1 and Cdx2.
    Funakoshi S; Ezaki T; Kong J; Guo RJ; Lynch JP
    Mol Cancer Res; 2008 Sep; 6(9):1478-90. PubMed ID: 18819935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of APC and AXIN2 expression by intestinal tumor suppressor CDX2 in colon cancer cells.
    Olsen AK; Coskun M; Bzorek M; Kristensen MH; Danielsen ET; Jørgensen S; Olsen J; Engel U; Holck S; Troelsen JT
    Carcinogenesis; 2013 Jun; 34(6):1361-9. PubMed ID: 23393221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of enhancer elements by the homeobox gene Cdx2 is cell line specific.
    Taylor JK; Levy T; Suh ER; Traber PG
    Nucleic Acids Res; 1997 Jun; 25(12):2293-300. PubMed ID: 9171078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and localisation of insulin receptor substrate 2 in normal intestine and colorectal tumours. Regulation by intestine-specific transcription factor CDX2.
    Modica S; Morgano A; Salvatore L; Petruzzelli M; Vanier MT; Valanzano R; Esposito DL; Palasciano G; Duluc I; Freund JN; Mariani-Costantini R; Moschetta A
    Gut; 2009 Sep; 58(9):1250-9. PubMed ID: 19221108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown GREM1 suppresses cell growth, angiogenesis, and epithelial-mesenchymal transition in colon cancer.
    Liu Y; Li Y; Hou R; Shu Z
    J Cell Biochem; 2019 Apr; 120(4):5583-5596. PubMed ID: 30426548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the tumor suppressor homeogene Cdx2 by HNF4α in intestinal cancer.
    Saandi T; Baraille F; Derbal-Wolfrom L; Cattin AL; Benahmed F; Martin E; Cardot P; Duclos B; Ribeiro A; Freund JN; Duluc I
    Oncogene; 2013 Aug; 32(32):3782-8. PubMed ID: 22986531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal Carcinogenesis.
    Kobayashi H; Gieniec KA; Wright JA; Wang T; Asai N; Mizutani Y; Lida T; Ando R; Suzuki N; Lannagan TRM; Ng JQ; Hara A; Shiraki Y; Mii S; Ichinose M; Vrbanac L; Lawrence MJ; Sammour T; Uehara K; Davies G; Lisowski L; Alexander IE; Hayakawa Y; Butler LM; Zannettino ACW; Din MO; Hasty J; Burt AD; Leedham SJ; Rustgi AK; Mukherjee S; Wang TC; Enomoto A; Takahashi M; Worthley DL; Woods SL
    Gastroenterology; 2021 Mar; 160(4):1224-1239.e30. PubMed ID: 33197448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDX2-regulated expression of iron transport protein hephaestin in intestinal and colonic epithelium.
    Hinoi T; Gesina G; Akyol A; Kuick R; Hanash S; Giordano TJ; Gruber SB; Fearon ER
    Gastroenterology; 2005 Apr; 128(4):946-61. PubMed ID: 15825077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer genetic variants are also associated with serrated polyposis syndrome susceptibility.
    Arnau-Collell C; Soares de Lima Y; Díaz-Gay M; Muñoz J; Carballal S; Bonjoch L; Moreira L; Lozano JJ; Ocaña T; Cuatrecasas M; Díaz de Bustamante A; Castells A; Capellà G; Bujanda L; Cubiella J; Rodríguez-Alcalde D; Balaguer F; Ruiz-Ponte C; Valle L; Moreno V; Castellvi-Bel S
    J Med Genet; 2020 Oct; 57(10):677-682. PubMed ID: 32170005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDX2 regulates multidrug resistance 1 gene expression in malignant intestinal epithelium.
    Takakura Y; Hinoi T; Oue N; Sasada T; Kawaguchi Y; Okajima M; Akyol A; Fearon ER; Yasui W; Ohdan H
    Cancer Res; 2010 Sep; 70(17):6767-78. PubMed ID: 20699370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GREM1 and POLE variants in hereditary colorectal cancer syndromes.
    Rohlin A; Eiengård F; Lundstam U; Zagoras T; Nilsson S; Edsjö A; Pedersen J; Svensson J; Skullman S; Karlsson BG; Björk J; Nordling M
    Genes Chromosomes Cancer; 2016 Jan; 55(1):95-106. PubMed ID: 26493165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.